Ralf Mohrbacher

872 total citations
18 papers, 318 citations indexed

About

Ralf Mohrbacher is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, Ralf Mohrbacher has authored 18 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Surgery and 6 papers in Genetics. Recurrent topics in Ralf Mohrbacher's work include Microscopic Colitis (13 papers), Inflammatory Bowel Disease (6 papers) and Hidradenitis Suppurativa and Treatments (3 papers). Ralf Mohrbacher is often cited by papers focused on Microscopic Colitis (13 papers), Inflammatory Bowel Disease (6 papers) and Hidradenitis Suppurativa and Treatments (3 papers). Ralf Mohrbacher collaborates with scholars based in Germany, Denmark and Lithuania. Ralf Mohrbacher's co-authors include Roland Greinwald, Michael Vieth, Ole K. Bonderup, Stephan Miehlke, Ahmed Madisch, Limas Kupčinskas, Fernando Fernández‐Bañares, Torben Nathan, Karin Dilger and Ralph Müeller and has published in prestigious journals such as Gastroenterology, International Journal of Molecular Sciences and Clinical Gastroenterology and Hepatology.

In The Last Decade

Ralf Mohrbacher

18 papers receiving 314 citations

Peers

Ralf Mohrbacher
Gilles Macaigne France
Jalel Boubaker Tunisia
A. D’Arienzo Italy
Serge Naegels Belgium
R Schiöler Sweden
Aurelio Lorenzo Spain
Ebby George Simon India
Purushothaman Premchand United Kingdom
Cristina Cijevschi Prelipcean Romania
J R Lowes United Kingdom
Gilles Macaigne France
Ralf Mohrbacher
Citations per year, relative to Ralf Mohrbacher Ralf Mohrbacher (= 1×) peers Gilles Macaigne

Countries citing papers authored by Ralf Mohrbacher

Since Specialization
Citations

This map shows the geographic impact of Ralf Mohrbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Mohrbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Mohrbacher more than expected).

Fields of papers citing papers by Ralf Mohrbacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Mohrbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Mohrbacher. The network helps show where Ralf Mohrbacher may publish in the future.

Co-authorship network of co-authors of Ralf Mohrbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Mohrbacher. A scholar is included among the top collaborators of Ralf Mohrbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Mohrbacher. Ralf Mohrbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Isola, Jorma, Markku Mäki, Martin Hils, et al.. (2023). The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment. International Journal of Molecular Sciences. 24(13). 10815–10815. 14 indexed citations
2.
Taavela, Juha, Alina Popp, Ralf Mohrbacher, et al.. (2022). 827: TRANSGLUTAMINASE 2 (TG2) INHIBITOR PROTECTS GLUTEN-INDUCED INTESTINAL DAMAGE IN CELIAC DISEASE: TRANSCRIPTOMIC ANALYSIS OF A RANDOMIZED GLUTEN CHALLENGE STUDY. Gastroenterology. 162(7). S–205. 1 indexed citations
3.
Münch, Andreas, Emese Mihály, Ferenc Nagy, et al.. (2021). Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo‐controlled multicentre trial. United European Gastroenterology Journal. 9(7). 837–847. 5 indexed citations
4.
Fiehn, Anne‐Marie Kanstrup, Stephan Miehlke, Daniela E. Aust, et al.. (2020). Distribution of histopathological features along the colon in microscopic colitis. International Journal of Colorectal Disease. 36(1). 151–159. 19 indexed citations
5.
Kruis, Wolfgang, Olena Levchenko, Sayar Abdulkhakov, et al.. (2018). Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis. Clinical Gastroenterology and Hepatology. 17(1). 98–106.e4. 18 indexed citations
6.
Münch, Andreas, Curt Tysk, Johan Bohr, et al.. (2015). Smoking Status Influences Clinical Outcome in Collagenous Colitis. Journal of Crohn s and Colitis. 10(4). 449–454. 23 indexed citations
7.
Miehlke, Stephan, Ahmed Madisch, Limas Kupčinskas, et al.. (2014). Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis. Gastroenterology. 146(5). 1222–1230.e2. 91 indexed citations
8.
Kreisel, Wolfgang, Peter Deibert, Limas Kupčinskas, et al.. (2014). The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Digestive and Liver Disease. 47(2). 144–150. 39 indexed citations
9.
Kruis, Wolfgang, Salam Zakko, Harald Peeters, et al.. (2014). 1052 Daily Mesalamine Fails to Prevent Recurrent Diverticulitis in a Large Placebo Controlled Multicenter Trial. Gastroenterology. 146(5). S–187. 9 indexed citations
10.
Miehlke, Stephan, Ahmed Madisch, L. Kupčinskas, et al.. (2013). P510 European multicenter trial of budesonide and mesalazine for short-term treatment of active collagenous colitis (BUC60/COC). Journal of Crohn s and Colitis. 7. S214–S214. 2 indexed citations
11.
Kruis, Wolfgang, Thomas Eisenbach, H Löhr, et al.. (2013). 808 Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial of Mesalamine for the Prevention of Recurrence of Diverticulitis. Gastroenterology. 144(5). S–139. 11 indexed citations
12.
Aust, Daniela E., Andreas Münch, Martin Olesen, et al.. (2013). Su1183 Topographical Distribution of Collagenous Colitis - A Pooled Histological Analysis of 2 European Prospective Multicenter Trials. Gastroenterology. 144(5). S–421. 8 indexed citations
13.
Miehlke, Stephan, Ahmed Madisch, Limas Kupčinskas, et al.. (2012). 1158 Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, Multicenter Trial of Budesonide and Mesalamine in Collagenous Colitis. Gastroenterology. 142(5). S–211. 8 indexed citations
14.
Sharon, Elad, Jürgen Finke, Michael Koldehoff, et al.. (2011). Improvement in Oral Chronic Graft-versus-Host Disease with the Administration of Effervescent Tablets of Topical Budesonide—An Open, Randomized, Multicenter Study. Biology of Blood and Marrow Transplantation. 18(1). 134–140. 18 indexed citations
15.
Andus, Tilo, Andrey Baranovsky, Ingolf Cascorbi, et al.. (2010). Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis. Inflammatory Bowel Diseases. 16(11). 1947–1956. 47 indexed citations
16.
Jong, Dirk J. de, et al.. (2009). T1218 Effects of Corticosteroids On Bone Metabolism in Patient with Active Crohn's Disease. Gastroenterology. 136(5). A–524. 1 indexed citations
17.
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilles Macaigne Breakdown of academic impact, for papers by Jalel Boubaker Breakdown of academic impact, for papers by A. D’Arienzo Breakdown of academic impact, for papers by Serge Naegels Breakdown of academic impact, for papers by R Schiöler Breakdown of academic impact, for papers by Aurelio Lorenzo Breakdown of academic impact, for papers by Ebby George Simon Breakdown of academic impact, for papers by Purushothaman Premchand Breakdown of academic impact, for papers by Cristina Cijevschi Prelipcean Breakdown of academic impact, for papers by J R Lowes
Rankless by CCL
2026